The Dow Chemical shares are slumping 4.2% to $54.58 on Thursday as the possible merger with chemical company Pont de Nemours is likely to receive intense scrutiny from antitrust regulators, the Wall Street Journal reports.
If the deal were to go through, it could be a merger of equals, where the combined company could separate into material sciences, specialty products and agrochemicals.
However, officials will closely examine the deal that would create a company with a market capitalization of over $130 billion. The concern is that regulators could block the merger as they have done so previously with several high-profile deals, the Journal noted.
Despite these uncertainties, analysts believe a deal “could well meet regulatory muster,” since the two companies do not directly compete in a lot of the biggest products and could exit assets in areas where they do overlap, the Journal added.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI